AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters

Apolipoprotein C2 (ApoC2) is a key activator of lipoprotein lipase for plasma triglyceride metabolism. ApoC2-deficient patients present with severe hypertriglyceridemia and recurrent acute pancreatitis, for whom the only effective treatment is the infusion of normal plasma containing ApoC2. However,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Methods Clin Dev
Principais autores: Yang, Chun, Tian, Wenhong, Ma, Sisi, Guo, Mengmeng, Lin, Xiao, Gao, Fengying, Dong, Xiaoyan, Gao, Mingming, Wang, Yuhui, Liu, George, Xian, Xunde
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7424175/
https://ncbi.nlm.nih.gov/pubmed/32802915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.07.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados